Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
05 June 2019 | Story Ruan Bruwer
Louzanne Coetzee
Athlete Louzanne Coetzee with the trophy of the Free State Sports Association for the Physically Disabled as Sports Star of the Year.

Although challenging, very exciting and a new journey, says Louzanne Coetzee about the athletics year for which she has been recognised.

The 26-year-old, who is doing her master’s in Social Cohesion and Reconciliation Studies at the University of the Free State, won the Free State Sports Association for the Physically Disabled (FSSAPD) Sports Star of the Year award for a fourth consecutive time. This was for the period June 2018 to April 2019.

In that time, she set a world record, an Africa record, and ran two marathons in which she came amazingly close to a second world record.

Only in her second marathon at the Berlin Marathon in September, the Paralympian fell 26 seconds short of the T11 (totally blind) world record time. She met the qualifying time for the 2020 Paralympic Games in Tokyo during the London Marathon in April.

“Marathons are definitely challenging and a new field for me, but I would say it has been a good 12 months. My aim is now set on next year’s Paralympic Games, where I would like to compete in the marathon and the 1 500 m.”

“I hope to run a good time in the 1 500 m at the World Para Athletics Championships in November.”

At the SASAPD National Championships for physically disabled and visually impaired athletes in April 2019, Coetzee won three gold medals and set a record in the 1 500 m. 

Others from the UFS also honoured

Coetzee has received several awards in her career, but says it is always special to be rewarded by her own federation (FSSAPD). 

Danie Breitenbach (T11) was also honoured as the Senior Male Sports Star. He bagged two gold medals and one silver and set a SA record in both the 800 m and 1 500 m at the nationals. Another Kovsie, Dineo Mokhosoa (F36 – coordination impairments), received a merit award for her gold medal in shot-put and silver in the discus at the national champs.

News Archive

New research informs improved treatment of brain inflammation
2017-10-13

Description: Sebolai and Ogundeji Tags: Microbiologist, Dr Adepemi Ogundeji,  

Dr Adepemi Ogundeji, researcher in the Department of Microbial,
Biochemical and Food Biotechnology at the
University of the Free State,
and Dr Olihile Sebolai,
her study leader from the same department.
Photo: Charl Devenish



Microbiologist Dr Adepemi Ogundeji has uncovered a new use for an old medicine that can potentially save lives and money. Under the guidance of her study leader, Dr Olihile Sebolai, Dr Ogundeji set out to fight a fungal disease caused by Cryptococcus neoformans. Drs Ogundeji and Sebolai are from the University of the Free State Department of Microbial, Biochemical and Food Biotechnology. 

Dr Ogundeji is passionate about education. “My aim will always be to transfer knowledge and skills in the microbiology field,” she said. “Dr Ogundeji’s study is celebrated in that it found a new purpose for existing medicines. An advantage of repositioning old medicines is by-passing clinical trials, which sometimes take 20 years, and the safety of such medicines is already known,” Dr Sebolai, explained.

Cryptococcus infections are difficult to control and often lead to brain inflammation. In layman’s terms: “Your brain is on fire”. People with HIV/Aids are especially vulnerable, surviving only about three months without treatment. Such patients may present with a Cryptococcus-emergent psychosis, and some with an out-of-control inflammatory condition when initiated on ARVs. 

Dr Ogundeji found that the clinically recommended dosage of aspirin (anti-inflammatory medicine), and quetiapine (anti-psychotic medicine) is sufficient to control the infection. Her exceptional work was readily published in some of the foremost journals in her field, namely, Antimicrobial Agents and Chemotherapy and Frontiers in Microbiology

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept